Genomic Medicine Institute Adds Seven Additional Illumina Genome Analyzers
News Jul 23, 2009
Illumina has announced that the Genomic Medicine Institute (GMI) at Seoul National University College of Medicine in Korea, purchased seven additional Illumina Genome AnalyzerIIx sequencing systems, expanding the capacity of their recently established Asian Genome Center to 10 Illumina sequencing systems.
“GMI’s decision to add seven additional Genome Analyzers is further validation that our sequencing platform is delivering leading performance with its unmatched rate of daily output, ease of use and proven paired-end sequencing capabilities,” said Tim Orpin, general manager of Illumina’s Asia Pacific Region.
Dr. Jeong-Sun Seo, director of the Genomic Medicine Institute, and his team, have completed a deep sequencing project of the Korean genome and the work was published online in Nature July 8, 2009. “This publication demonstrates the global competitiveness of GMI’s technological capabilities and provides a practical example of Korean bio-medical excellence,” said Dr. Seo.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019